Skip to content
OpenCapital
Get started

iRadimed IRMD EBITDA margin

EBITDA margin at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
15.5%-1.1pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
20.2%+0.9pp
ICU Medical logo
ICU MedicalICUI
11.4%-0.2pp
ITG
Integer HoldingsITGR
18.3%-0.8pp
RadNet logo
RadNetRDNT
10.4%-0.8pp
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc. IRTC
-2.9%-1.3pp

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0×0.0×
Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

ebitda/total revenue=34.1%

Based on trailing twelve months.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's EBITDA margin?
iRadimed (IRMD) reported EBITDA margin of 34.1% in Q1 2026.
How has iRadimed's EBITDA margin changed year-over-year?
iRadimed's EBITDA margin increased by 9.2% year-over-year, from 31.2% to 34.1%.
What is the long-term trend for iRadimed's EBITDA margin?
Over 3 years (2021 to 2025), iRadimed's EBITDA margin has grown at a 6.7% compound annual growth rate (CAGR), from 26.8% to 32.6%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.